Published in Blood Weekly, June 3rd, 2004
The results show that Theralux, a non-invasive process used outside the body (ex vivo) to treat disorders affecting the blood and bone marrow, was able to completely eradicate cancer cells from autologous stem cell grafts in 88% of patients.
The objective of the present study was to determine the safety of the Theralux process and whether the process could eliminate lymphoma cells from a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.